Company Filing History:
Years Active: 2002
Title: Innovations of Stephen Feldman in Interferon Research
Introduction
Stephen Feldman is a notable inventor based in Passaic, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of interferon research. With a total of 2 patents to his name, Feldman's work focuses on the isolation and purification of natural type I interferons derived from leukocytes.
Latest Patents
Feldman's latest patents revolve around the compositions of highly-purified natural mixtures of type I interferon. These inventions detail methods for isolating highly purified mixtures of natural type I interferon from white blood cells. The highly purified mixtures include at least 9 subtypes, such as alpha-1, alpha-2, alpha-5, alpha-7, alpha-8, alpha-10, alpha-14, alpha-21, and omega. This results in the creation of at least 16, and possibly 20 or more molecular species, which are crucial for various therapeutic applications.
Career Highlights
Stephen Feldman is associated with Viragen Incorporated, a company that focuses on biopharmaceuticals. His work has been instrumental in advancing the understanding and application of interferons in medical treatments. His innovative approaches have paved the way for new therapeutic strategies in the field of immunology.
Collaborations
Feldman has collaborated with notable colleagues such as Joseph P. Morris and Duy Nguyen. These collaborations have further enhanced the research and development of interferon-related therapies.
Conclusion
Stephen Feldman's contributions to the field of biotechnology, particularly in the area of interferon research, highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for patients.